BR112013014827A2 - formulações gástricas e colônicas e métodos para produzir e usar as mesmas - Google Patents
formulações gástricas e colônicas e métodos para produzir e usar as mesmasInfo
- Publication number
- BR112013014827A2 BR112013014827A2 BR112013014827A BR112013014827A BR112013014827A2 BR 112013014827 A2 BR112013014827 A2 BR 112013014827A2 BR 112013014827 A BR112013014827 A BR 112013014827A BR 112013014827 A BR112013014827 A BR 112013014827A BR 112013014827 A2 BR112013014827 A2 BR 112013014827A2
- Authority
- BR
- Brazil
- Prior art keywords
- gastric
- producing
- methods
- same
- colonic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42256710P | 2010-12-13 | 2010-12-13 | |
| PCT/AU2011/001609 WO2012079118A1 (en) | 2010-12-13 | 2011-12-13 | Gastric and colonic formulations and methods for making and using them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013014827A2 true BR112013014827A2 (pt) | 2016-10-04 |
Family
ID=46243884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013014827A BR112013014827A2 (pt) | 2010-12-13 | 2011-12-13 | formulações gástricas e colônicas e métodos para produzir e usar as mesmas |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10092573B2 (pt) |
| EP (1) | EP2651415B1 (pt) |
| JP (1) | JP6121334B2 (pt) |
| KR (1) | KR101947720B1 (pt) |
| CN (2) | CN103338768B (pt) |
| AU (1) | AU2011342368B2 (pt) |
| BR (1) | BR112013014827A2 (pt) |
| CA (1) | CA2821196C (pt) |
| DK (1) | DK2651415T3 (pt) |
| IL (1) | IL226831B (pt) |
| MX (1) | MX355760B (pt) |
| NZ (1) | NZ611868A (pt) |
| PL (1) | PL2651415T3 (pt) |
| SG (1) | SG191145A1 (pt) |
| WO (1) | WO2012079118A1 (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| BR112013014827A2 (pt) | 2010-12-13 | 2016-10-04 | Antony Wettstein | formulações gástricas e colônicas e métodos para produzir e usar as mesmas |
| JP6240610B2 (ja) * | 2011-10-27 | 2017-11-29 | サリックス ファーマシューティカルズ，インコーポレイテッド | 電解質下剤 |
| WO2014016671A2 (en) | 2012-07-27 | 2014-01-30 | Redhill Biopharma Ltd. | Formulations and methods of manufacturing formulations for use in colonic evacuation |
| JP2015531770A (ja) * | 2012-08-29 | 2015-11-05 | サリックス ファーマシューティカルズ，インコーポレイテッド | 緩下剤組成物、ならびに便秘および関連胃腸疾患および症状を処置するための方法 |
| PT2968174T (pt) | 2013-03-15 | 2020-01-15 | Braintree Laboratories Inc | Comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e seus métodos de utilização |
| JP6394142B2 (ja) * | 2013-07-25 | 2018-09-26 | 大正製薬株式会社 | 固形製剤 |
| KR101423005B1 (ko) * | 2013-10-17 | 2014-07-28 | 강윤식 | 장 세정용 조성물 |
| WO2015056897A1 (ko) * | 2013-10-17 | 2015-04-23 | 강윤식 | 장 세정용 조성물 |
| CN103550212A (zh) * | 2013-11-03 | 2014-02-05 | 王显著 | 含匹可硫酸和抗坏血酸的药物组合物 |
| RU2746548C2 (ru) * | 2014-11-04 | 2021-04-15 | Иннофармакс, Инк. | Пероральное введение неустойчивых или плохо всасывающихся лекарственных средств |
| GB201511255D0 (en) * | 2015-06-26 | 2015-08-12 | Colltec Ltd | Formulation |
| JP6460552B2 (ja) * | 2015-07-14 | 2019-01-30 | 国立大学法人大阪大学 | 筋強直性ジストロフィー治療薬 |
| CN106910184B (zh) * | 2017-01-12 | 2020-10-09 | 杭州电子科技大学 | 基于深度卷积神经网络的内窥镜图像肠道出血检测方法 |
| US10143656B1 (en) * | 2017-08-04 | 2018-12-04 | Braintree Laboratories, Inc. | Solid oral sulfate salt formulations for cleaning a colon and methods of using same |
| US10751365B2 (en) | 2018-01-12 | 2020-08-25 | Metimedi Pharmaceuticals Co., Ltd. | Methods of treating chronic inflammatory diseases |
| KR102111094B1 (ko) * | 2018-06-18 | 2020-05-14 | 주식회사 한국팜비오 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
| CN108904808A (zh) * | 2018-08-15 | 2018-11-30 | 西安力邦医药科技有限责任公司 | 一种治疗便秘的药物组合物及其应用 |
| CN109289095B (zh) * | 2018-11-23 | 2021-03-26 | 淮海工学院 | 一种含盐酸利多卡因的肠镜凝胶剂及其制备方法 |
| MX2021009841A (es) * | 2019-02-15 | 2021-12-15 | Seaford Pharmaceuticals Inc | Administracion oral de cloruro de sodio para prevenir complicaciones asociadas a la limpieza intestinal con laxantes estimulantes. |
| EP4093259A4 (en) * | 2020-01-20 | 2024-04-10 | Advanced Health Solutions LLC | COMPOSITIONS AND METHODS FOR IMPROVING VISIBILITY OF THE GASTROINTESTINAL TRACT DURING ENDOSCOPY PROCEDURES |
| US11554155B2 (en) | 2020-01-20 | 2023-01-17 | Advanced Health Solutions LLC | Compositions and methods for improving gastrointestinal function |
| CN111494313A (zh) * | 2020-05-25 | 2020-08-07 | 李会芳 | 一种用于母猪便秘治疗的灌肠液及其制备方法 |
| EP4232008A4 (en) * | 2020-10-26 | 2024-07-10 | Braintree Laboratories Inc | SALINE SULFATE FORMULATIONS FOR COLON CLEANSING |
| CN112587498A (zh) * | 2020-12-29 | 2021-04-02 | 哈尔滨瀚钧现代制药有限公司 | 多库酯钠丹蒽醌及其制备方法 |
| JP2024501839A (ja) * | 2020-12-31 | 2024-01-16 | テジュン ファーマシューティカル カンパニー リミテッド | 腸管洗浄用の経口固形製剤 |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA761927A (en) * | 1967-06-27 | Seeger Ernst | Benzoxazine derivatives | |
| US4186025A (en) | 1975-09-25 | 1980-01-29 | Merck & Co., Inc. | Aqueous polysaccharide composition |
| US4452779A (en) | 1982-02-03 | 1984-06-05 | Cockerill Vernon | Composition and method of treating lactating mammals |
| JPS58222020A (ja) * | 1982-06-18 | 1983-12-23 | Teijin Ltd | 前処置用下剤 |
| DK454683D0 (da) | 1983-10-03 | 1983-10-03 | Mogens Gjerloev | Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf |
| AU590578B2 (en) | 1985-04-18 | 1989-11-09 | Procter & Gamble Company, The | Treatment of non-ulcer dyspepsia with bismuth salts |
| US4766004A (en) | 1986-12-19 | 1988-08-23 | Warner-Lambert Company | Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition |
| IL86859A (en) | 1987-07-10 | 1991-12-15 | E Z Em Inc | Aqueous cathartic solution containing inorganic salts |
| JP2733849B2 (ja) | 1987-10-12 | 1998-03-30 | ボロディー，ソーマス・ユリウス | 胃腸障害治療のための改良された方法 |
| US5274001A (en) | 1987-12-24 | 1993-12-28 | Borody Thomas J | Orthostatic lavage solutions |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| EP0433299B1 (en) | 1988-08-02 | 1998-05-06 | Gastro Services Pty. Limited (ACN 002 994 890) | Treatment of gastro-intestinal disorders |
| US5213807A (en) | 1990-05-03 | 1993-05-25 | Chemburkar Pramod B | Pharmaceutical composition containing ibuprofen and a prostaglandin |
| US5232699A (en) | 1990-07-26 | 1993-08-03 | The Proctor & Gamble Company | Laxative compositions |
| US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| WO1992006690A1 (en) | 1990-10-22 | 1992-04-30 | Borody Thomas J | Treatment of non-inflammatory and non-infectious bowel disorders |
| US5173296A (en) | 1990-11-16 | 1992-12-22 | The Procter & Gamble Company | Compositions containing psyllium |
| JP3047143B2 (ja) | 1992-04-24 | 2000-05-29 | 堀井薬品工業株式会社 | 腸管洗浄液用組成物及び腸管洗浄液 |
| EP0724441A1 (en) | 1993-10-19 | 1996-08-07 | The Procter & Gamble Company | Picosulphate dosage form |
| JP3850891B2 (ja) | 1994-03-01 | 2006-11-29 | ゼリア新薬工業株式会社 | 緩下効果を有する組成物 |
| AUPM695294A0 (en) | 1994-07-20 | 1994-08-11 | Borody, Thomas Julius | Improved combination therapy dose unit |
| AUPM864894A0 (en) | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
| JP3010007B2 (ja) | 1995-05-22 | 2000-02-14 | ビオフェルミン製薬株式会社 | 配合下剤 |
| RU2098100C1 (ru) | 1995-10-11 | 1997-12-10 | Максимова Ирина Сергеевна | Ирригационный раствор для офтальмологических операций |
| US6103268A (en) | 1995-11-03 | 2000-08-15 | Borody; Thomas Julius | Administering osmotic colonic evacuant containing a picosulfate |
| AUPN634595A0 (en) | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
| AU771576B2 (en) | 1995-11-03 | 2004-03-25 | Red Hill Biopharma Ltd. | Improved preparation for colonic evacuation |
| NZ333493A (en) | 1995-11-03 | 2000-06-23 | Nicolas Peter Shortis | Method of evacuating a patient's colon by oral administration of an osmotic colonic evacuant in powder form |
| JP3423842B2 (ja) | 1996-01-19 | 2003-07-07 | 日研化学株式会社 | 変異株及び該変異株又は親株を用いるエリスリトールの製造方法 |
| US6087386A (en) | 1996-06-24 | 2000-07-11 | Merck & Co., Inc. | Composition of enalapril and losartan |
| DE69720379T2 (de) | 1996-12-02 | 2004-02-12 | Mitsubishi Chemical Corp. | Verfahren zur Herstellung von Erythritol |
| US5948787A (en) | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| KR19980075195A (ko) | 1997-03-26 | 1998-11-16 | 손경식 | 트리코스포로노이데스 속 변이균주 및 이를 이용한 에리스리톨의 제조방법 |
| US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
| US6551632B2 (en) | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| ES2303351T3 (es) | 1997-04-01 | 2008-08-01 | Thomas Julius Borody | Metodos y composiciones para tratar enfermedades intestinales inflamatorias. |
| CN1252711A (zh) * | 1997-04-18 | 2000-05-10 | 大正制药株式会社 | 微乳 |
| AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
| JP4092748B2 (ja) | 1997-09-05 | 2008-05-28 | ニプロ株式会社 | 腸管洗浄液 |
| KR100541578B1 (ko) | 1997-12-04 | 2006-04-06 | 미쓰비시 가가꾸 가부시키가이샤 | 에리트리톨 생산방법 |
| PL197989B1 (pl) | 1997-12-19 | 2008-05-30 | Smithkline Beecham Corp | Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego |
| AUPP325398A0 (en) | 1998-04-30 | 1998-05-21 | Borody, Thomas J. | Improved method for eradicating h. pylori |
| AUPP437698A0 (en) | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
| US6001616A (en) | 1998-09-16 | 1999-12-14 | Dong Cheon Consulting Co., Ltd. | Process for preparing erythritol using novel cell of pichia |
| EP1005863A1 (en) | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| US7763276B1 (en) | 1999-02-26 | 2010-07-27 | Shionogi & Co., Ltd. | Chewable soft capsules having improved administration properties and process for producing the same |
| US6858403B2 (en) | 1999-05-11 | 2005-02-22 | M-Biotech, Inc. | Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide |
| DE19930030B4 (de) | 1999-06-30 | 2004-02-19 | Meduna Arzneimittel Gmbh | CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform |
| CN1288730A (zh) * | 1999-09-07 | 2001-03-28 | 麦克内尔-Ppc股份有限公司 | 轻泻组合物 |
| JP2001114668A (ja) | 1999-10-13 | 2001-04-24 | Meiji Seika Kaisha Ltd | チョコレート剤 |
| US6774111B1 (en) | 2000-03-14 | 2004-08-10 | Abbott Laboratories | Carbohydrate system and a method for providing nutrition to a diabetic |
| JP2003531171A (ja) | 2000-04-19 | 2003-10-21 | トーマス ジュリアス ボロディー | 高脂血症関連疾患に対する組成物および治療 |
| US20030180260A1 (en) | 2000-06-19 | 2003-09-25 | Clancy Robert Llewellyn | Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor |
| AUPQ854100A0 (en) | 2000-07-03 | 2000-07-27 | Helirad Pty Ltd | Methods for monitoring treatment of helicobacter infection |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| WO2002071872A2 (en) | 2001-03-13 | 2002-09-19 | Kellogg Company | Aerated food component |
| US6790453B2 (en) | 2001-03-14 | 2004-09-14 | Mccormick & Company, Inc. | Encapsulation compositions and process for preparing the same |
| US7815956B2 (en) | 2001-04-27 | 2010-10-19 | Pepsico | Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products |
| WO2002098352A2 (en) | 2001-06-01 | 2002-12-12 | Pozen Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| EP1410794A1 (en) | 2001-07-05 | 2004-04-21 | Wakunaga Pharmaceutical Co., Ltd. | Soft capsules |
| US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
| AUPS017702A0 (en) | 2002-01-25 | 2002-02-14 | Atopic Pty Ltd | Methods and compositions for the treatment of asthma and related disorders |
| AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| US6753009B2 (en) * | 2002-03-13 | 2004-06-22 | Mcneil-Ppc, Inc. | Soft tablet containing high molecular weight polyethylene oxide |
| DK2425824T5 (en) | 2002-04-05 | 2018-02-12 | Mundipharma As | Pharmaceutical preparation containing oxycodone and naloxone |
| US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
| AU2003900553A0 (en) | 2003-02-10 | 2003-02-20 | Borody, Thomas Julius | Novel Improved Method for Detection of Dientamoeba fragilis and other Parasites |
| JP4458761B2 (ja) * | 2003-03-27 | 2010-04-28 | ロート製薬株式会社 | 瀉下用製剤 |
| CA2521420A1 (en) * | 2003-04-08 | 2004-10-28 | Progenics Pharmaceuticals, Inc. | Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| EP1620075B1 (en) * | 2003-05-07 | 2020-06-24 | Samyang Biopharmaceuticals Corporation | Highly plastic granules for making fast melting tablets |
| US7687075B2 (en) * | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
| WO2005099821A1 (en) * | 2004-04-13 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Use of simethicone in constipated patients |
| AU2004320512A1 (en) | 2004-06-04 | 2005-12-22 | Braintree Laboratories, Inc. | Method of bowel cleansing |
| KR100749229B1 (ko) * | 2005-04-29 | 2007-08-13 | (주)아모레퍼시픽 | 당 및 당알콜을 함유하는 변비개선용 조성물 |
| US20060275223A1 (en) | 2005-06-02 | 2006-12-07 | Burr James B | Erythritol compositions for teeth and gums |
| WO2007057924A1 (en) | 2005-11-21 | 2007-05-24 | Panacea Biotec Ltd | Laxative composition on the basis of triphala |
| DE602006018529D1 (de) | 2005-12-29 | 2011-01-05 | Osmotica Kereskedelmi Es Szolgaltato Kft | Mehrschichtige tablette mit dreifacher freisetzungskombination |
| US20070185145A1 (en) * | 2006-02-03 | 2007-08-09 | Royds Robert B | Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same |
| CN101033010A (zh) * | 2006-03-09 | 2007-09-12 | 麦迪森企业股份有限公司 | 塑料容器的内容物封装方法及其容器的制造流程 |
| JP5006567B2 (ja) | 2006-04-14 | 2012-08-22 | 花王株式会社 | 口腔用固形製剤 |
| WO2008021394A2 (en) * | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
| WO2008027442A2 (en) | 2006-08-30 | 2008-03-06 | Theraquest Biosciences, Llc | Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use |
| JP2008115085A (ja) * | 2006-11-01 | 2008-05-22 | Tendou Seiyaku Kk | 緩下剤 |
| AU2008253583A1 (en) * | 2007-05-17 | 2008-11-27 | David Lubowski | Combination laxative compositions comprising a colonic stimulant and a bulking laxative |
| US8821928B2 (en) | 2007-06-04 | 2014-09-02 | Egalet Ltd. | Controlled release pharmaceutical compositions for prolonged effect |
| KR20160083132A (ko) | 2007-06-06 | 2016-07-11 | 바스프 에스이 | 급속 붕해 정제의 제조를 위한 제약 제제 |
| US20100184785A1 (en) | 2007-06-06 | 2010-07-22 | Basf Se | Pharmaceutical formulation for the production of chewable tablets and lozenges |
| EP2264042B1 (en) | 2007-07-27 | 2012-07-18 | Cargill, Incorporated | Micronization of polyols |
| EP2196221A4 (en) | 2007-09-27 | 2011-12-28 | Mitsubishi Tanabe Pharma Corp | SOLID PREPARATION WITH QUICK DISINTEGRATION |
| EP2205213A2 (en) | 2007-10-01 | 2010-07-14 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
| BRPI0816513A2 (pt) | 2007-10-19 | 2015-03-24 | Purdue Research Foundation | Composição farmacêutica e método para preparar a suspensão sólida |
| JP5258268B2 (ja) | 2007-11-19 | 2013-08-07 | フロイント産業株式会社 | 球形粒の製造方法 |
| US20090155363A1 (en) | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
| JP5352474B2 (ja) | 2007-12-28 | 2013-11-27 | 沢井製薬株式会社 | 口腔内崩壊錠およびその製造方法 |
| US20090258090A1 (en) | 2008-04-11 | 2009-10-15 | Braintree Laboratories, Inc. | Colon cleansing solution |
| US20100178413A1 (en) | 2008-12-17 | 2010-07-15 | Mark Gorris | Food-based Supplement Delivery System |
| US20100285164A1 (en) | 2009-05-11 | 2010-11-11 | Jrs Pharma | Orally Disintegrating Excipient |
| US20120064133A1 (en) | 2009-05-28 | 2012-03-15 | Ishwar Chauhan | Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations |
| US20110218216A1 (en) | 2010-01-29 | 2011-09-08 | Kumaravel Vivek | Extended release pharmaceutical composition of donepezil |
| BR112013014827A2 (pt) | 2010-12-13 | 2016-10-04 | Antony Wettstein | formulações gástricas e colônicas e métodos para produzir e usar as mesmas |
| JP6240610B2 (ja) | 2011-10-27 | 2017-11-29 | サリックス ファーマシューティカルズ，インコーポレイテッド | 電解質下剤 |
| WO2014016671A2 (en) | 2012-07-27 | 2014-01-30 | Redhill Biopharma Ltd. | Formulations and methods of manufacturing formulations for use in colonic evacuation |
| JP2015531770A (ja) | 2012-08-29 | 2015-11-05 | サリックス ファーマシューティカルズ，インコーポレイテッド | 緩下剤組成物、ならびに便秘および関連胃腸疾患および症状を処置するための方法 |
-
2011
- 2011-12-13 BR BR112013014827A patent/BR112013014827A2/pt not_active IP Right Cessation
- 2011-12-13 JP JP2013543468A patent/JP6121334B2/ja active Active
- 2011-12-13 CA CA2821196A patent/CA2821196C/en active Active
- 2011-12-13 WO PCT/AU2011/001609 patent/WO2012079118A1/en active Application Filing
- 2011-12-13 US US13/993,294 patent/US10092573B2/en active Active
- 2011-12-13 MX MX2013006641A patent/MX355760B/es active IP Right Grant
- 2011-12-13 DK DK11848334.6T patent/DK2651415T3/da active
- 2011-12-13 PL PL11848334T patent/PL2651415T3/pl unknown
- 2011-12-13 AU AU2011342368A patent/AU2011342368B2/en not_active Ceased
- 2011-12-13 CN CN201180066402.6A patent/CN103338768B/zh active Active
- 2011-12-13 EP EP11848334.6A patent/EP2651415B1/en active Active
- 2011-12-13 KR KR1020137017334A patent/KR101947720B1/ko active IP Right Grant
- 2011-12-13 SG SG2013045604A patent/SG191145A1/en unknown
- 2011-12-13 NZ NZ611868A patent/NZ611868A/en not_active IP Right Cessation
- 2011-12-13 CN CN201910226481.0A patent/CN110200954A/zh active Pending
-
2013
- 2013-06-09 IL IL226831A patent/IL226831B/en active IP Right Grant
-
2018
- 2018-10-02 US US16/149,927 patent/US20190240229A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2821196C (en) | 2022-11-22 |
| CA2821196A1 (en) | 2012-06-21 |
| AU2011342368B2 (en) | 2016-11-17 |
| EP2651415A1 (en) | 2013-10-23 |
| KR20140018210A (ko) | 2014-02-12 |
| US10092573B2 (en) | 2018-10-09 |
| US20130296314A1 (en) | 2013-11-07 |
| PL2651415T3 (pl) | 2021-04-19 |
| EP2651415A4 (en) | 2014-04-23 |
| CN103338768A (zh) | 2013-10-02 |
| MX355760B (es) | 2018-04-27 |
| EP2651415B1 (en) | 2020-10-07 |
| SG191145A1 (en) | 2013-07-31 |
| JP2014502598A (ja) | 2014-02-03 |
| IL226831B (en) | 2018-02-28 |
| NZ611868A (en) | 2015-11-27 |
| WO2012079118A1 (en) | 2012-06-21 |
| DK2651415T3 (da) | 2020-11-30 |
| AU2011342368A1 (en) | 2013-05-09 |
| MX2013006641A (es) | 2013-11-04 |
| US20190240229A1 (en) | 2019-08-08 |
| KR101947720B1 (ko) | 2019-02-14 |
| CN103338768B (zh) | 2019-04-19 |
| JP6121334B2 (ja) | 2017-04-26 |
| CN110200954A (zh) | 2019-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013014827A2 (pt) | formulações gástricas e colônicas e métodos para produzir e usar as mesmas | |
| DK2648809T3 (da) | Naturlige formuleringer | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK3661211T3 (da) | Billedforudsigelse-afkodningsfremgangsmåde | |
| DK3257500T3 (da) | Apixabanformuleringer | |
| BR112013020383A2 (pt) | formulações liofilizadas. | |
| SMT201700110B (it) | Composizione immunogena | |
| FI9350U1 (fi) | Ravintoformulaatioita | |
| BR112013003319A2 (pt) | soquete | |
| BR112013012755A2 (pt) | projetor | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| DK3072505T3 (da) | Testosteronformuleringer | |
| UA21334S (uk) | Цукерка | |
| BR112012022411A2 (pt) | articulador | |
| ES1072516Y (es) | Muñeco hinchable | |
| DOS2010000249S (es) | Confiteria | |
| BR112013031218A2 (pt) | protetores solares | |
| CO6801767A2 (es) | Formulaciones de liberación sostenida de paracetamol | |
| DK2672817T3 (da) | Forbedrede insekticide formuleringer | |
| BR112013031107A2 (pt) | protetores solares | |
| BR112013030369A2 (pt) | composições de cb-183,315 e métodos relacionados | |
| FI20115631A0 (fi) | Immunostimulatoriset yhdisteet ja niiden käyttö | |
| EP2536407A4 (en) | TAXAN-PRO-EMULSION FORMULATIONS AND METHOD FOR THEIR MANUFACTURE AND USE | |
| FR2967069B3 (fr) | Formulations | |
| DK2598472T3 (da) | Formuleringer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: SALIX PHARMACEUTICALS, INC. (US) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2700 DE 04-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |